BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 24293317)

  • 21. CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1.
    Ward AJ; Rimer M; Killian JM; Dowling JJ; Cooper TA
    Hum Mol Genet; 2010 Sep; 19(18):3614-22. PubMed ID: 20603324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative splicing mediates the compensatory upregulation of MBNL2 upon MBNL1 loss-of-function.
    Nitschke L; Hu RC; Miller AN; Lucas L; Cooper TA
    Nucleic Acids Res; 2023 Feb; 51(3):1245-1259. PubMed ID: 36617982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2.
    Carpentier C; Ghanem D; Fernandez-Gomez FJ; Jumeau F; Philippe JV; Freyermuth F; Labudeck A; Eddarkaoui S; Dhaenens CM; Holt I; Behm-Ansmant I; Marmier-Gourrier N; Branlant C; Charlet-Berguerand N; Marie J; Schraen-Maschke S; Buée L; Sergeant N; Caillet-Boudin ML
    Biochim Biophys Acta; 2014 Apr; 1842(4):654-64. PubMed ID: 24440524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy.
    Wang PY; Lin YM; Wang LH; Kuo TY; Cheng SJ; Wang GS
    Hum Mol Genet; 2017 Jun; 26(12):2247-2257. PubMed ID: 28369378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MBNL1 overexpression is not sufficient to rescue the phenotypes in a mouse model of RNA toxicity.
    Yadava RS; Kim YK; Mandal M; Mahadevan K; Gladman JT; Yu Q; Mahadevan MS
    Hum Mol Genet; 2019 Jul; 28(14):2330-2338. PubMed ID: 30997488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
    Dansithong W; Paul S; Comai L; Reddy S
    J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive impairment of muscle regeneration in muscleblind-like 3 isoform knockout mice.
    Poulos MG; Batra R; Li M; Yuan Y; Zhang C; Darnell RB; Swanson MS
    Hum Mol Genet; 2013 Sep; 22(17):3547-58. PubMed ID: 23660517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zebrafish mbnl mutants model physical and molecular phenotypes of myotonic dystrophy.
    Hinman MN; Richardson JI; Sockol RA; Aronson ED; Stednitz SJ; Murray KN; Berglund JA; Guillemin K
    Dis Model Mech; 2021 Jun; 14(6):. PubMed ID: 34125183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy Brain.
    Goodwin M; Mohan A; Batra R; Lee KY; Charizanis K; Fernández Gómez FJ; Eddarkaoui S; Sergeant N; Buée L; Kimura T; Clark HB; Dalton J; Takamura K; Weyn-Vanhentenryck SM; Zhang C; Reid T; Ranum LP; Day JW; Swanson MS
    Cell Rep; 2015 Aug; 12(7):1159-68. PubMed ID: 26257173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity.
    Terenzi F; Ladd AN
    RNA Biol; 2010; 7(1):43-55. PubMed ID: 20009516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models.
    Cerro-Herreros E; Sabater-Arcis M; Fernandez-Costa JM; Moreno N; Perez-Alonso M; Llamusi B; Artero R
    Nat Commun; 2018 Jun; 9(1):2482. PubMed ID: 29946070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscleblind-like1 undergoes ectopic relocation in the nuclei of skeletal muscles in myotonic dystrophy and sarcopenia.
    Malatesta M; Giagnacovo M; Costanzo M; Cisterna B; Cardani R; Meola G
    Eur J Histochem; 2013 Apr; 57(2):e15. PubMed ID: 23807294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
    Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
    ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences.
    Sellier C; Cerro-Herreros E; Blatter M; Freyermuth F; Gaucherot A; Ruffenach F; Sarkar P; Puymirat J; Udd B; Day JW; Meola G; Bassez G; Fujimura H; Takahashi MP; Schoser B; Furling D; Artero R; Allain FHT; Llamusi B; Charlet-Berguerand N
    Nat Commun; 2018 May; 9(1):2009. PubMed ID: 29789616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy.
    Du H; Cline MS; Osborne RJ; Tuttle DL; Clark TA; Donohue JP; Hall MP; Shiue L; Swanson MS; Thornton CA; Ares M
    Nat Struct Mol Biol; 2010 Feb; 17(2):187-93. PubMed ID: 20098426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deprivation of Muscleblind-Like Proteins Causes Deficits in Cortical Neuron Distribution and Morphological Changes in Dendritic Spines and Postsynaptic Densities.
    Lee KY; Chang HC; Seah C; Lee LJ
    Front Neuroanat; 2019; 13():75. PubMed ID: 31417371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models.
    Bargiela A; Sabater-Arcis M; Espinosa-Espinosa J; Zulaica M; Lopez de Munain A; Artero R
    Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25203-25213. PubMed ID: 31754023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.
    Li M; Zhuang Y; Batra R; Thomas JD; Li M; Nutter CA; Scotti MM; Carter HA; Wang ZJ; Huang XS; Pu CQ; Swanson MS; Xie W
    Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5472-5477. PubMed ID: 32086392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of MBNL and CELF mRNA transcripts in muscles with myotonic dystrophy.
    Nezu Y; Kino Y; Sasagawa N; Nishino I; Ishiura S
    Neuromuscul Disord; 2007 Apr; 17(4):306-12. PubMed ID: 17331722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing.
    Pascual M; Vicente M; Monferrer L; Artero R
    Differentiation; 2006 Mar; 74(2-3):65-80. PubMed ID: 16533306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.